EVIO, Inc. (EVIO) Stock Analysis

EVIO, Inc. (EVIO) Healthcare & Pipeline Overview

EVIO, Inc. provides analytical testing and advisory services to the U.S. cannabis industry, offering consulting, product formulation, and comprehensive testing services. With a focus on cannabinoid potency, pesticide screening, and regulatory compliance, EVIO supports cannabis businesses in navigating the complex landscape of the evolving market.

What Is the Investment Thesis for EVIO?

EVIO, Inc. presents a focused play on the cannabis testing and advisory services market. With a P/E ratio of 1.67 and a gross margin of 33.0%, the company demonstrates potential profitability. Growth catalysts include the expansion of cannabis legalization across states, driving demand for testing and compliance services. Key risks include intense competition and the evolving regulatory landscape. Investors should monitor revenue growth, profitability improvements, and the company's ability to adapt to changing regulations in the cannabis industry.

Based on FMP financials and quantitative analysis

EVIO Key Highlights

EVIO, Inc. operates in the cannabis analytical testing and advisory services market within the United States.

• The company's profit margin is 3.0%, indicating a potential for improvement in operational efficiency.
• EVIO's gross margin stands at 33.0%, reflecting its ability to manage the cost of services effectively.
• The company's P/E ratio is 1.67, suggesting it may be undervalued compared to its earnings.
• EVIO's beta is 81.01, indicating high volatility compared to the market.

Who Are EVIO's Competitors?

EVIO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are EVIO's Key Strengths?

Comprehensive suite of testing and advisory services.

• Expertise in cannabis testing and compliance.
• Established relationships with cannabis businesses.
• Reputation for accuracy and reliability.

What Are EVIO's Weaknesses?

Small size and limited resources.

• Dependence on the cannabis industry.
• Limited geographic reach.
• High beta indicating high volatility.

What Could Drive EVIO Stock Higher?

Expansion into new states legalizing cannabis, increasing demand for testing services.

• Increasing regulatory scrutiny in the cannabis industry, driving demand for compliance services.
• Strategic partnerships with cannabis cultivators, processors, and retailers.

What Are the Key Risks for EVIO?

Negative return on equity (-0.4%) — the business is not currently generating profit on shareholder capital.

• Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
• Intense competition from other testing labs and consulting firms.
• Evolving regulatory landscape and potential changes in cannabis laws.
• Economic downturn affecting the cannabis industry.
• Limited financial disclosure due to OTC listing.
• Low trading volume and liquidity on the OTC market.

What Are the Growth Opportunities for EVIO?

• Expansion into New Geographies: As more states legalize cannabis, EVIO has the opportunity to expand its testing and advisory services into these new markets. This geographic expansion can significantly increase its revenue base. The timeline for this growth is dependent on the pace of legalization in different states, but it represents a substantial long-term growth opportunity. By establishing testing facilities and building relationships with local cannabis businesses, EVIO can capitalize on the growing demand for its services.
• Development of New Testing Services: EVIO can expand its service offerings to include more specialized testing services, such as heavy metal analysis or genetic testing of cannabis strains. These new services can attract a wider range of customers and increase revenue per client. The timeline for developing these services depends on the availability of technology and expertise, but it represents a valuable opportunity to differentiate EVIO from its competitors. This diversification can enhance EVIO's competitive advantage and market position.
• Strategic Partnerships: Forming strategic partnerships with cannabis cultivators, processors, and retailers can provide EVIO with a steady stream of clients and revenue. These partnerships can also help EVIO expand its geographic reach and service offerings. The timeline for establishing these partnerships depends on the company's ability to build relationships and negotiate favorable terms. However, these partnerships can provide a significant boost to EVIO's growth and profitability.
• Increased Regulatory Scrutiny: As the cannabis industry matures, regulatory scrutiny is likely to increase, driving demand for EVIO's compliance and testing services. This trend presents a significant growth opportunity for the company. The timeline for this growth is dependent on the actions of regulatory bodies, but it is likely to be a long-term trend. By staying ahead of the curve and offering comprehensive compliance solutions, EVIO can position itself as a trusted partner for cannabis businesses.
• Product Formulation and Advisory Services: EVIO can leverage its expertise in cannabis testing to offer product formulation and advisory services to cannabis businesses. This can help these businesses develop new and innovative products that meet regulatory requirements and consumer demand. The timeline for this growth depends on the company's ability to attract and retain talented scientists and consultants, but it represents a valuable opportunity to expand its service offerings and increase revenue.

What Are EVIO's Competitive Advantages?

• Specialized expertise in cannabis testing and compliance.
• Established relationships with cannabis businesses.
• Comprehensive suite of testing and advisory services.
• Reputation for accuracy and reliability.

What Does EVIO Do?

EVIO, Inc. was established to provide analytical testing and advisory services to businesses operating within the burgeoning cannabis industry in the United States. Recognizing the need for standardized testing and regulatory compliance in this rapidly evolving market, EVIO has positioned itself as a key service provider for cannabis cultivators, processors, and retailers. The company offers a comprehensive suite of services, including consulting, product formulation, and licensing and compliance assistance. Its analytical testing services encompass cannabinoid potency testing, terpene analysis, pesticide testing, residual solvent screening, visual inspections, and biological contaminant testing. These services are designed to ensure product safety, quality, and compliance with state and local regulations. Headquartered in Henderson, Nevada, EVIO, Inc. aims to support the growth and legitimacy of the cannabis industry by providing reliable and accurate testing and advisory solutions.

What Products and Services Does EVIO Offer?

• Provides analytical testing services to the cannabis industry.
• Offers consulting services related to cannabis product formulation.
• Assists cannabis businesses with licensing and compliance.
• Conducts cannabinoid potency testing.
• Performs terpene analysis.
• Screens for pesticides and residual solvents.
• Conducts visual inspections of cannabis products.
• Tests for biological contaminants.

How Does EVIO Make Money?

• Generates revenue through analytical testing services for cannabis products.
• Earns fees from consulting services related to product formulation and regulatory compliance.
• Partnerships with cannabis cultivators, processors, and retailers.
• Offers specialized testing services, such as heavy metal analysis and genetic testing.

What Industry Does EVIO Operate In?

EVIO, Inc. operates within the rapidly expanding cannabis industry, which is experiencing significant growth due to increasing legalization and acceptance across the United States. The market for cannabis testing and advisory services is becoming increasingly important as regulations tighten and consumers demand safer, more reliable products. Competition is intensifying, with numerous testing labs and consulting firms vying for market share. EVIO's success depends on its ability to maintain high standards of accuracy, compliance, and customer service in this dynamic environment.

Who Are EVIO's Key Customers?

• Cannabis cultivators
• Cannabis processors
• Cannabis retailers
• Cannabis product manufacturers

EVIO, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

Return on equity for EVIO, Inc. stands at -0.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.7%, showing how much profit it generates from its asset base. EVIO trades at a trailing price-to-earnings ratio of 1.67, below the Healthcare sector average of ~21.50x. Its free cash flow yield is -37.5%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.04 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 29.9%, the inverse of the P/E and a quick read on earnings relative to price.

Company Profile

EVIO, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Henderson, US. The company is led by CEO Lori Jean Glauser. EVIO has traded publicly since 2004.

The most recent 9 insider filings for EVIO, Inc. break down as 1 sales and 8 purchases. On net that is roughly 4.4M shares acquired (about $422K) — insiders putting money in tends to read as conviction.

EVIO Financials

EVIO Latest News

EVIO Analyst Consensus

EVIO MoonshotScore

What Investors Ask About EVIO, Inc. (EVIO) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources